Objectives: Patients with dementia in the acute setting are generally considered to impose higher costs on the health system compared to those without the disease largely due to longer length of stay (LOS). Many studies exploring the economic impact of the disease extrapolate estimates based on the costs of patients diagnosed using routinely collected hospital discharge data only. However, much dementia is undiagnosed, and therefore in limiting the analysis to this cohort, we believe that LOS and the associated costs of dementia may be overestimated. We examined LOS and associated costs in a cohort of patients specifically screened for dementia in the hospital setting.
between 50% and 80% of people affected having no formal diagnosis of their condition. [6] [7] [8] [9] [10] [11] Furthermore, it has been identified that dementia is underestimated in hospital registries, [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] due to limitations with coding systems, insufficient diagnoses, and the failure to document and record dementia as a diagnosis even when the diagnosis has been established. 12, 13, 20 Reports of the prevalence rate of dementia in the acute care setting range from 3.9% to 22%, depending on the hospital and age cohort under consideration. 7, 12, 22 A recent Irish multihospital observational study identified a dementia prevalence of 25% amongst older hospitalised patients of whom just over 35% had a previously known diagnosis (listed in GP letter, medical notes, or report of a family member). Of those with a known diagnosis of dementia, only 20%
of cases had been captured by the hospital inpatient enquiry (HIPE) registry. 13, 15 Patients with dementia in the acute setting are generally considered to impose higher costs on the health system. This is reflected in longer length of stay (LOS) compared to those the same age without the disease, 7, 12, 16, 17, 20, [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] increased risk of in-hospital complications, 21, 34 safety and behavioural issues requiring 1:1 care, and a higher risk of readmission. 21 However, many of these studies that explore the economic impact of the disease extrapolate estimates based on the costs of formally diagnosed patients only. 23, 33, [35] [36] [37] An
Irish study examining the additional hospital days due to dementia estimated an associated annual cost of >€ 199 million to the Irish health system. 35 These marginal costs were determined by assessing the additional LOS for those with a known diagnosis of dementia captured by the HIPE system and multiplying this excess LOS by the estimated dementia hospital admissions based on European age-specific prevalence rates. 35 However, in limiting the analysis of a dementia cohort to those with a formal diagnosis only, and by extension the most severely impaired patients, we believe that LOS in hospital and the associated costs of dementia may be overestimated.
In light of the hypothesis that dementia imposes higher direct medical costs on the health system largely due to longer LOS in hospital, but with supporting evidence that much dementia is undiagnosed, our study examines LOS and associated costs in a cohort that was specifically screened for dementia in the hospital setting.
Using primary data collected by Timmons et al 15 on the true prevalence of dementia in the hospital setting, we can accurately compare LOS and associated costs for those with and without dementia. With an ageing demographic profile and the consequent economic pressures on the health system, robust data on the prevalence and the economic impact of dementia on the acute setting are required. This information is fundamental to inform policy makers on appropriate resource allocation in planning for a sustainable health system and highlighting priorities for future research.
| METHODS
We used primary data from a nonconsecutive, prospective cohort study of patients aged ≥70 years, including elective (non day case)
and unplanned admissions to any speciality across six acute hospitals 
Key points
• Studies that explore the economic impact of dementia by extrapolating estimates based on the length of stay and costs of patients diagnosed using routinely collected hospital discharge data only may be overestimated.
• When patients were screened for dementia on admission to the acute setting, we found no significant difference in overall length of stay and total costs between those with and without the disease.
• Accurate disease prevalence data, encompassing all stages of disease severity, is required to enable an estimation of the true costs of dementia in the acute setting based on length of stay. 42 Due to the study's perspective, the public inpatient per diem costs were also applied to the private hospital included in the analysis.
To estimate the cost of a SC, we assumed that for the case of male patients, SCs were male porters, and for female patients, SCs were female health care assistants. This decision was made in agreement with the consulting geriatrician (ST). Salaries were determined from the New Entrant (midpoint) Health Sector Salary Scales effective from 1 July 2013. 43 As per guidelines issued by the Irish Health Information and Quality Authority, 44 salaries were adjusted for employer's social insurance, imputed pension costs, and overheads, from which a daily cost for a SC was estimated.
| Statistical analysis
Data were entered into FileMaker Pro 11 database and transferred to SPSS version 22 (IBM Co., Chicago, IL, USA) for analysis. Descriptive statistics of patient characteristics are presented as frequencies and percentages, and continuous variables are presented as mean ± SD.
Due to positively skewed LOS and hospital cost data, we applied nonparametric techniques to analyse the data. A series of Mann-Whitney U tests were performed to compare differences in LOS and costs between the two patient groups, that is, those with and without hospital-diagnosed dementia. A chi-square test for independence was conducted to indicate the association between dementia status and the presence of a SC. The daily cost of a SC was subject to sensitivity analysis where the cost was varied by + and -50%. Statistical significance was determined using P < 0.05.
3 | RESULTS
| Overview of all patients enrolled in the study
Of the 594 patients enrolled in the study, 304 (51.2%) were female and 290 (48.8%) were male, ranging in age from 70 to 99 years (μ = 79.7 years, SD = 6.6). The majority of patients were based in a public hospital (81.1%) and admitted via the emergency department (70.9%). Medical admissions (66.2%) were most prevalent followed by surgical (21.4%), and geriatric and orthopaedic combined (12.3%).
The most common presenting diagnosis was surgery/procedure (19.7%), followed by cardiac conditions (16.8%), pneumonia (10.9%), gastrointestinal issues (9.3%), and respiratory illnesses (7.2%). In terms of the patients' living arrangements prior to admittance, 62.3%
patients were living at home with their partner or other family members, almost 30% were living on their own, and the remaining patients were resident in a nursing home (5.9%) or came from sheltered accommodation (3%). 
| Length of stay
Mean LOS in hospital for the study cohort was 8.66 days (min. = 1, max. = 219, SD = 12.88). The average LOS in the dementia group was 9.9 days (SD = 11.20) ("previously diagnosed dementia" = 10.19 days and "research-categorised as dementia; not previously diagnosed" = 9.74 days). This compared with 8.25 days (SD = 13.38) for those without dementia ( Table 1) . The difference between the two cohorts was nonsignificant (P = 0.108).
The difference in LOS between the two groups was interrogated using the following categories: gender, age group, admission type, hospital type and location, speciality of the admitting team, patient living arrangements prior to admittance to hospital, and patient discharge arrangements and primary diagnosis at admission (Table 1) .
Results varied, but mean LOS was shorter for those with a dementia diagnosis in the following instances on admission: to a rural hospital, geriatric and orthopaedic admitting team, coming from a sheltered home, and coming from a nursing home. At admission, patients were diagnosed with 1 of 10 conditions. In the case of four of these conditions, respiratory, infection, stroke, and surgery/procedure, mean LOS was shorter for those with a dementia diagnosis. Based on destination at discharge alone, mean LOS was shorter for the dementia cohort compared to the cohort without dementia when discharged to nursing homes for long-term care and to short-term care facilities (noting that 60% of those with dementia discharged to a nursing home already resided there preadmission, compared to 50% of those without dementia). When patients died in hospital, the number of days to death was shorter in the cohort with dementia. Discharge to home was the only instance where mean LOS was longer in the group with dementia.
Significant differences in LOS were observed between the two groups in two categories: (i) the patient's living arrangements prior to admission to hospital and (ii) the primary diagnosis at admission.
A longer LOS was observed for the dementia cohort (μ = 11.61 days) compared to the nondementia group (μ = 7.55 days) in the case where they were living with a partner or other family member prior to admission. Conversely, a shorter LOS was identified in the dementia group (μ = 2.4 days) compared to the nondementia group (μ = 5.87 days) where the admitting diagnosis was for a surgical procedure.
| Special carers
Thirty-six patients in total (6.1% of the study cohort) required one-to- an inpatient bed for the study cohort was € 7158 (SD = € 10 574). The mean cost for patients with dementia was € 8186 (SD = € 9262), higher than those without dementia (μ = € 6816, SD = € 10 963).
However, the difference of € 1370 was not statistically significant.
| SC
The daily cost of a SC was calculated as € 161 for a male SC and € 169 for a female SC. The average total cost of a special carer was € 730 (min. = €161, max. = €3864, SD = € 869), but lower for patients with dementia (μ = € 555, SD = € 522), compared to those without dementia (μ = € 871, SD = € 1063). Again, the difference in mean cost was not statistically significant.
| Total cost
Combining the cost of an inpatient bed and the cost of a special carer, the mean total cost per patient in the study cohort was € 7202 (SD = € 10 654). A comparison of total costs between the two patient cohorts revealed higher costs for those with dementia (μ = € 8246 dementia vs € 6855 no dementia ) ( Table 2 ), (μ = € 8512 previously 
| DISCUSSION
Current estimates of the cost of dementia in the hospital setting typically use the difference in LOS between a dementia and nondementia patient cohort as a proxy for the marginal cost of the disease along with reported prevalence rates to determine the total cost of the disease. 21, 31, 33 This limits analyses to patients with a formal diagnosis of the disease. Although these studies do highlight the fact that their analysis is limited to formally diagnosed patients, they mainly postulate that disease costs are underestimated due to the underdiagnosis of the disease. 17, 21 However, this study highlights the potential nuances present in this approach. In terms of identifying the marginal cost of the disease, we propose that using LOS data for the dementia patient group from hospital registries, specifically patients with a formal diagnosis, limits the analysis to a more severely impaired population and therefore may not lead to an accurate measurement of costs. To our knowledge, this is the first study that compares direct hospital resource utilisation and costs between patients with and without dementia where the disease is specifically diagnosed in the hospital setting.
Our study finds no significant difference in terms of LOS and associated costs between those with and without dementia. The findings are aligned with a study performed within the German Study on Ageing, Cognition and Dementia in Primary Care Patients, which considered the net costs of dementia by disease stage. Similarly, no significant differences in mean annual costs for inpatient treatment were found between dementia and nondementia patients. 45 While subjects for this German study were recruited through GPs, dementia was also specifically diagnosed as part of the study by an experienced geriatrician or geriatric psychiatrist. 46 Our study findings highlight the fact that continued use of hospital discharge/ registry-based data for sourcing dementia prevalence rates and associated LOS in order to calculate dementia care costs in the hospital setting may provide misleading estimates and should be treated with caution.
| Limitations
Given that previous studies largely determine the direct medical costs of dementia primarily based on hospital LOS data, we confined our analysis of hospital costs to the cost of an inpatient bed based on LOS and the cost of a special carer based on length of time with the carer. We acknowledge that this does not allow us to capture the full cost of inpatient hospital care. However, we believe that with accurate prevalence data, an analysis of costs based on LOS provides a valid starting point for comparing the true costs of inpatient care for those with and without dementia.
While the cost of SCs has been estimated based on the salaries of fulltime permanent staff, we are aware that porters and health care assistants in Ireland are frequently hired through agencies and so in reality would be more expensive. Whilst it is not feasible to cost for SCs hired through agencies for this study, we have calculated the daily cost based solely on the number of working days in the year, that is, excluding weekend days, public holidays, and an annual leave allowance of 25 days. Furthermore, the cost of special carers has been subject to sensitivity analysis where the cost was stressed by + and −50%, with no impact on the results.
| CONCLUSION
Dementia has been described as the greatest global challenge for health and social care this century, 47 with a risk that health care systems could be overwhelmed by the costs of providing care for those with the disease into the future. 48 
